Faculty profile

Nisha Thampi

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Nisha Thampi

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
4 publications in the last five years, latest in 2025.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clostridioides Difficile (C. Difficile)Covid-19 Environmental Surveillance Influenza Long-Term Care Homes Nosocomial Infections Pathogen Surveillance Respiratory Syncytial Virus (Rsv)

Latest papers

COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study.
Vaccine · 2025
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection.
Heliyon · 2024
COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization.
Pediatrics · 2023

All 11 publications

Latest funding

Surveillance of Healthcare and Ambient Pathogens in our Environments and Spaces [SHAPES]
CIHR · 2022 · Principal investigator
$100,000

All 1 grants and awards

11 publications.

COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study.

Piché-Renaud PP, Drover SSM, Austin PC, Morris SK, Buchan SA, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson SE, Wilson K, Guttmann A, Kwong JC

Vaccine2025

DOI: 10.1016/j.vaccine.2024.126539 PMID: 39617675

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection.

Naveed Z, Chu C, Tadrous M, Veroniki AA, Li J, Rouleau I, Febriani Y, Calzavara A, Buchan SA, Nasreen S, Schwartz KL, Wilton J, Seo CY, Thampi N, Wilson SE, Naus M, De Serres G, Janjua NZ, Kwong JC, Canadian Immunization Research Network (CIRN) Provincial Collaborative Network investigators

Heliyon2024

DOI: 10.1016/j.heliyon.2024.e26551 PMID: 38439866

COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization.

Piché-Renaud PP, Swayze S, Buchan SA, Wilson SE, Austin PC, Morris SK, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson K, Kwong JC, CANADIAN IMMUNIZATION RESEARCH NETOWRK (CIRN) PROVINICAL COLLABORATIVE INVESTIGATORS

Pediatrics2023

DOI: 10.1542/peds.2022-059513 PMID: 36866446

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.

Buchan SA, Alley S, Seo CY, Johnson C, Kwong JC, Nasreen S, Thampi N, Lu D, Harris TM, Calzavara A, Wilson SE

JAMA pediatrics2023

DOI: 10.1001/jamapediatrics.2022.6166 PMID: 36848096

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T

CANADIAN MEDICAL ASSOCIATION JOURNAL201863 citationsSenior author

DOI: 10.1503/cmaj.180013

Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care.

Thampi N, Showler A, Burry L, Bai AD, Steinberg M, Ricciuto DR, Bell CM, Morris AM

American journal of infection control2015First author

DOI: 10.1016/j.ajic.2015.01.031 PMID: 25769617

Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study.

Schwartz KL, Darwish I, Richardson SE, Mulvey MR, Thampi N

BMC pediatrics2014Senior author

DOI: 10.1186/1471-2431-14-28 PMID: 24485120

Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors.

Thampi N, Stephens D, Rea E, Kitai I

The Pediatric infectious disease journal2012First author

DOI: 10.1097/inf.0b013e318239134c PMID: 22016079

Pro/con debate: are barrier precautions cost-effective in improving patient outcomes in the intensive care unit?

Thampi N, Morris AM

Critical care (London, England)2012First author

DOI: 10.1186/cc10532 PMID: 22264293

Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.

Hawkes M, Opoka RO, Namasopo S, Miller C, Conroy AL, Serghides L, Kim H, Thampi N, Liles WC, John CC, Kain KC

Medical hypotheses2011

DOI: 10.1016/j.mehy.2011.06.003 PMID: 21745716

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Clostridioides Difficile (C. Difficile) Dear Professor Thampi, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Surveillance of Healthcare and Ambient Pathogens in our Environments and Spaces [SHAPES]" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Nisha Thampi

Research

Latest papers

Latest funding

COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study.

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection.

COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization.

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)

Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care.

Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study.

Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors.

Pro/con debate: are barrier precautions cost-effective in improving patient outcomes in the intensive care unit?

Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.

Surveillance of Healthcare and Ambient Pathogens in our Environments and Spaces [SHAPES]

Frequent collaborators

Nisha Thampi

Mina Tadrous

Kumanan Wilson

Dominik Mertz

Dominik Mertz

Dominik Mertz

Monica Taljaard

Areti-Angeliki Veroniki

Monica Taljaard

Dat Tran

Michelle Science

Lisa Burry

Monica Taljaard

Monica Taljaard

Patricia Parkin

Susy Hota

Yves Longtin

Gaston De Serres

Yves Longtin

Gaston De Serres

Dominik Mertz

Elizabeth Rea

Astrid Guttmann

Lena Serghides

Nisha Thampi

Research

Latest papers

Latest funding

COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11&#xa0;years in Ontario: A Canadian immunization research network (CIRN) study.

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection.

COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization.

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)

Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care.

Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study.

Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors.

Pro/con debate: are barrier precautions cost-effective in improving patient outcomes in the intensive care unit?

Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.

Surveillance of Healthcare and Ambient Pathogens in our Environments and Spaces [SHAPES]

Frequent collaborators

Nisha Thampi

Mina Tadrous

Kumanan Wilson

Dominik Mertz

Dominik Mertz

Dominik Mertz

Monica Taljaard

Areti-Angeliki Veroniki

Monica Taljaard

Dat Tran

Michelle Science

Lisa Burry

Monica Taljaard

Monica Taljaard

Patricia Parkin

Susy Hota

Yves Longtin

Gaston De Serres

Yves Longtin

Gaston De Serres

Dominik Mertz

Elizabeth Rea

Astrid Guttmann

Lena Serghides

COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study.